Intended Use
The Gliadin IgG Antibody ELISA Test Kit has been designed for the detection and the quantitative determination of specific IgG antibodies against Gliadin in serum and plasma. Further applications in other body fluids are possible and can be requested from the Technical Service. This assay is intended for research use only.
Contents of Kit
Store kit components at 2-8°C and do not use after the expiry date on the box outer label. Before use, all components should be allowed to warm up to ambient temperature (18- 25°C). After use, the plate should be resealed, the bottle caps replaced and tightened and the kit stored at 2-8°C. The opened kit should be used within three months.
Mikrotiter Strips: 12 strips with 8 breakable wells each, coated with a Gliadin antigen (purified gluten antigen from wheat). Ready-to-use.
Calibrator A (Negative Control): 2 mL, protein solution diluted with PBS, contains no IgG antibodies against Gliadin. Addition of 0.01 % methylisothiazolone and 0.01 % bromonitrodioxane. Ready-to-use.
Calibrator B (Cut-Off Standard): 2 mL human serum diluted with PBS, contains a low concentration of IgG antibodies against Gliadin. Addition of 0.01 % methylisothiazolone and 0.01 % bromonitrodioxane. Ready-to-use.
Calibrator C (Weak Positive Control): 2 mL, human serum diluted with PBS, contains a medium concentration of IgG antibodies against Gliadin. Addition of 0.01 % methylisothiazolone and 0.01% bromonitrodioxane. Ready-to-use.
Calibrator D (Positive Control): 2 mL, human serum dilute with PBS, contains a high concentration of IgG antibodies against Gliadin. Addition of 0.01 % methylisothiazolone and 0.01 % bromonitrodioxane. Ready-to-use.
Enzyme Conjugate: 15 mL, anti-human-IgG-HRP (rabbit), in protein-containing buffer solution. Ready-to-use.
Substrate: 15 mL, TMB (tetramethylbenzidine). Ready-touse.
Stop Solution: 15 mL, 0.5 M sulfuric acid. Ready-to-use.
Sample Diluent: 60 mL, PBS/BSA buffer. Addition of 0.095% sodium azide. Ready-to-use.
Washing Buffer: 60 mL, PBS+Tween 20, 10× concentrate. Final concentration: dilute 1+9 with distilled water. If during the cold storage crystals precipitate, the concentrate should be warmed up at 37°C for 15 minutes.
Plastic Foils: 2 pieces to cover the microtiter strips during the incubation.
Plastic Bag: Resealable, for the dry storage of non-used strips.
Storage
Store kit at 2-8°C. It is stable up to the expiry date stated on the label of the box. Do not use kit beyond its expiry date.
Performance Characteristics
General Description
Gliadin is the main component of gluten, which occurs in wheat and other domestic grain types like rye, barley and oats, and may lead to severe diseases of the intestinal mucosa in sensitive children and adults. Celiac disease, a gluten-induced enteropathy, appears rather frequently (1 case on 300 births) and is a typical example of a non-IgE mediated food allergy. Genetically, histocompatibility antigens on the chromosome 6 are responsible for the disease. Celiac disease manifests itself practically as a constant reaction against gliadin. By the toxic effect of gluten in the intestinal tract, antibodies, cytokines and lymphocytes are released, which lead to internal lesions and inflammations. Further, the microvilli of the intestine are almost completely reduced, so that the inner intestinal surface becomes flat. The resulting malabsorption leads to a deficit of above all trace elements and vitamins. Loss of weight, diarrhea, flatulence and abdominal pain are observed as symptoms. An invasive diagnostic possibility represents the biopsy of the intestinal mucosa. In addition serological methods for the determination of IgG and IgA antibodies against gliadin, reticulin and endomysium in the patient serum are increasingly used as a screening method. For children with a gluten-sensitive enteropathy, the incidence was calculated to 90-100%, for adults with celiac disease 75- 90% and for dermatitis herpetiformis 40-50%. Elevated levels of IgA anti-gliadin demonstrate an active process and are in close correlation with a villous atrophy in children. The ELISA antibody determination is also well suited for the monitoring of patients after a gluten-free diet.
Citations
Publication ()
Have you cited DEIA274 in a publication?
Let us know and earn a reward for your research.